Friday, July 31, 2026

SK쉴더스 & TUV SUD: How This Partnership Enhances OT Security Compliance for Asian Businesses

SK Shieldus and TUV SUD partner to enhance cybersecurity compliance for companies expanding globally amid tightening regulations.

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

O’Brien: U.S. Needs More from Allies to Counter China

On the 23rd, Robert O'Brien once again argued that South Korea needs to increase its defense cost-sharing, insisting on its insufficiency.

Tag: Capital Markets Act

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.